ctrl-trade
All companies

LLY vs MRK

Eli Lilly and Company and Merck & Co., Inc., side by side.

Eli Lilly and Company
LLY Drug Manufacturers - General

Eli Lilly and Company

$1,126.80 on May 29, 2026
View full LLY profile →
Merck & Co., Inc.
MRK Drug Manufacturers - General

Merck & Co., Inc.

$119.89 on May 29, 2026
View full MRK profile →

Figures reflect each company's latest snapshot — no metric is a verdict on its own. New to these numbers? Learn how to read them →

Company Size

How large is this company relative to the overall market?

Metric LLY MRK

Company Size

$1.00T · Mega-cap

$296.11B · Mega-cap

Valuation

Is this stock priced cheaply or expensively relative to its earnings and revenue?

Metric LLY MRK

P/E Ratio

40.0x

33.8x

Forward P/E

25.3x

12.5x

Price-to-Sales

13.9x

4.5x

Profitability

How efficiently does the company turn revenue into profit?

Metric LLY MRK

Profit Margin

35.0%

13.6%

Gross Margin

82.8%

76.7%

Return on Equity

107.5%

18.9%

Growth

Is the business expanding — or contracting?

Metric LLY MRK

Revenue Growth

55.5%

4.9%

Earnings Growth

169.9%

Financial Health

Can the company handle its debts and short-term obligations?

Metric LLY MRK

Debt-to-Equity

1.39x

1.07x

Current Ratio

1.50x

1.30x

Dividends

Does the company pay shareholders regular cash income?

Metric LLY MRK

Dividend Yield

0.6%

2.7%

Risk & Volatility

How much does this stock move relative to the overall market?

Metric LLY MRK

Volatility (Beta)

0.48x

0.20x

Analyst View

What do professional Wall Street analysts say about this stock?

Metric LLY MRK

Analyst Consensus

Buy (29 analysts)

Buy (27 analysts)

Analyst Target Price

$1215.10

+7.8% vs price

$129.74

+8.2% vs price
Early access

Research done. Time to trade.

Ctrl-Trade is the options trading app built for beginners who want to trade like pros — find opportunities, manage positions with ease, and stay profitable.

No spam. Unsubscribe any time.